Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 35 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
ODC1
💬1. ODC1
| [3] Arginine and proline metabolism Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways | Eflornithine
Eflornithine
💬1. ODC1
| Eflornithine | [1] 65 65 💬1. ODC1
| ||||||||||||||||||||||||||||||||||||
| 2 |
OPRD1
💬2. OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction [3] cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interact ... | Nalmefene
Nalmefene
💬2. OPRD1
| Nalmefene | [1] 6 6 💬2. OPRD1
| ||||||||||||||||||||||||||||||||||||
| 3 |
OPRD1
💬3. OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction [3] cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interact ... | Naltrexone
Naltrexone
💬3. OPRD1
| Naltrexone | [13] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬3. OPRD1
| ||||||||||||||||||||||||||||||||||||
| 4 |
OPRD1
💬4. OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction [3] cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interact ... | Oxycodone
Oxycodone
💬4. OPRD1
| Oxycodone | [5] 6 6, 13, 70, 226, 298 💬
| ||||||||||||||||||||||||||||||||||||
| 5 |
OPRD1
💬5. OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction [3] cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interact ... | Loperamide
Loperamide
💬5. OPRD1
| Loperamide | [2] 13 13, 97 💬
| ||||||||||||||||||||||||||||||||||||
| 6 |
OPRD1
💬6. OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction [3] cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interact ... | Nalbuphine
Nalbuphine
💬6. OPRD1
| Nalbuphine | [1] 85 85 💬6. OPRD1
| ||||||||||||||||||||||||||||||||||||
| 7 |
OPRD1
💬7. OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction [3] cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interact ... | Naloxone
Naloxone
💬7. OPRD1
| Naloxone | [2] 6 6, 226 💬
| ||||||||||||||||||||||||||||||||||||
| 8 |
OPRK1
💬8. OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Dezocine
Dezocine
💬8. OPRK1
| Dezocine | [1] 46 46 💬8. OPRK1
| ||||||||||||||||||||||||||||||||||||
| 9 |
OPRK1
💬9. OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Nalmefene
Nalmefene
💬9. OPRK1
| Nalmefene | [1] 6 6 💬9. OPRK1
| ||||||||||||||||||||||||||||||||||||
| 10 |
OPRK1
💬10. OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Naltrexone
Naltrexone
💬10. OPRK1
| Naltrexone | [13] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬10. OPRK1
|